Funded Tech Companies
LTZ Therapeutics
Wondering who invested in LTZ Therapeutics? Lapam Capital, GL Ventures and K2 Venture Capital invested in this biopharmaceutical company.
Company Overview
Company Name
LTZ Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1100 Island Dr. 103
Redwood City, 94065
USA
Redwood City, 94065
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
LTZ Therapeutics is an immunotherapy-focused biotech company pursuing the development of novel therapies to improve clinical outcomes in patients with cancer and other diseases with an unmet clinical need. LTZ is focused on leveraging the power of innate immunity (e.g., macrophages) and elimination of immunosuppression (e.g., T regulatory cells, cancer-associated fibroblasts) as these areas have been shown to offer tremendous potential for developing innovative and effective therapies. Specifically, LTZ is developing its own novel innate engager platform to effectively activate macrophages in addition to natural killing (NK) cells as effectors to deliver direct anti-tumor and anti-immunosuppressive cell killing and promote inflammation in the tumor microenvironment -- indirectly resulting in activated adaptive immunity and long-term memory.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/30/2024
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Li
Chief Scientific Officer
Martin Treder
Co-Founder
Jianhui Zhou
Company Investors
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs